Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DCS5 | ISIN: US60785L2079 | Ticker-Symbol:
NASDAQ
20.11.24
21:57 Uhr
2,055 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MODULAR MEDICAL INC Chart 1 Jahr
5-Tage-Chart
MODULAR MEDICAL INC 5-Tage-Chart

Aktuelle News zur MODULAR MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.11.Modular Medical, Inc. - 10-Q, Quarterly Report-
11.11.Modular Medical, Inc.: Modular Medical Proudly Sponsors the Inaugural Achieving Diabetes Equity in Practice Today Conference209SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump...
► Artikel lesen
08.11.Modular Medical, Inc.: Registration Is Now Open For Tribe Public's Webinar Event "Tailoring GLP-1 Weight Loss Treatments: Innovative Approaches To Personalized Dosing" Featuring Modular Medical CEO On Monday, November 11, 2024156Meet with Modular Medical CEO, Jeb BesserObesity is linked to 30% to 53% of new diabetes cases in the U.S. every year, per research in the Journal of the American Heart AssociationAbout half of all...
► Artikel lesen
07.11.Modular Medical, Inc.: Modular Medical Announces Results from a Successful GLP-1 Proof of Concept Study204-Study showed more potent weight loss and blood glucose control with the addition of a mealtime bolus of a rapid acting GLP-1 to basal delivery- Observed weight loss was 17% at 28 days, a 25% improvement...
► Artikel lesen
31.10.New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR's "Hack of the Week"258The episode, airing at 9:30 PM PST, will include insights from The Sustainable Green Team with CEO Tony Raynor and Jimmy Houston.NEW YORK, NY / ACCESSWIRE / October 31, 2024 / New to The Street, a premier...
► Artikel lesen
28.10.New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical , Acurx Pharmaceuticals , and LightPath Technologies200Also appearing on the show are, Sustainable Green Team (OTCQX:SGTM), Andie Monet with David Fagen, and SEKUR (OTCQX:SWISF)NEW YORK, NY / ACCESSWIRE / October 28, 2024 / New to The Street on Fox Business...
► Artikel lesen
30.09.Modular Medical, Inc.: Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1208SAN DIEGO, CA / ACCESSWIRE / September 30, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump...
► Artikel lesen
18.09.Modular Medical reports issuance of U.S. patent covering key aspects of core pumping technology5
MODULAR MEDICAL Aktie jetzt für 0€ handeln
18.09.Modular Medical secures patent for insulin pum3
18.09.Modular Medical sichert sich Patent für Insulinpumpe7
18.09.Modular Medical, Inc.: Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology166Allowed claims cover major features of pumping mechanism in FDA-cleared MODD1 productSAN DIEGO, CA / ACCESSWIRE / September 18, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company")...
► Artikel lesen
11.09.Modular Medical, Inc.: Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform425-Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024-Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for people...
► Artikel lesen
09.09.Modular Medical, Inc.: Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024227Meet with Modular Medical CEO, Jeb BesserThere are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US.100% of patient population require daily insulin...
► Artikel lesen
05.09.Why Is Modular Medical Stock Up Today?1
05.09.Modular Medical, Inc. - 8-K, Current Report1
05.09.Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket1
05.09.Modular Medical, Inc.: Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump524SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market...
► Artikel lesen
04.09.Modular Medical gets FDA nod for diabetes patch pum1
04.09.Modular Medical, Inc.: Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump361MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial...
► Artikel lesen
27.08.Modular Medical announces executive option grants1
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1